Table 1. Patient demographics and characteristics.
| Characteristics | Findings |
|---|---|
| Patients number | 79 |
| Mean age (yr) | 66.1 (SD 12.3) |
| Body mass index (kg/m2) | 22.2 (SD 3.5) |
| Sex | |
| Male | 60 (75.9%) |
| Female | 19 (24.1%) |
| Admission days | 37.8 (SD 30.5) |
| Mortality (dead/alive) | 10/69 |
| Follow up duration (mon) | 20.0 (SD 22.3) |
| Wagner classification | |
| Stage III | 67 (84.8%) |
| Stage IV | 12 (15.2%) |
| CVA and CAD | 14/79 (17.7%) |
| ABI | 0.98 (SD 0.31) |
| Hemoglobin (g/dL) | 10.7 (SD 1.7) |
| WBC count (103/µL) | 10.6 (SD 4.2) |
| Total protein (g/dL) | 6.6 (SD 0.8) |
| ESR (mm/h) | 68.6 (SD 29.3) |
| CRP (mg/L) | 7.8 (SD 7.6) |
| BUN (mg/dL) | 24.6 (SD 17.3) |
| Cr (mg/dL) | 2.5 (SD 2.7) |
| AST (IU/L) | 26.9 (SD 21.9) |
| ALT (IU/L) | 25.5 (SD 38.1) |
| Glucose (fasting) (mg/dL) | 185.5 (SD 112.6) |
| Hemoglobin A1c (%) | 8.6 (SD 2.0) |
CVA, cerebrovascular accident; CAD, coronary artery disease; ABI, ankle brachial index; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; BUN, blood urea nitrogen; Cr, serum creatinine; AST, aspartate aminotransferase; ALT, alanine aminotransferase. Normally distributed data recorded as mean (standard deviation).